Skip to content

UWINHEALTH

  • Health News
  • Health Problems
  • Family Health
    • Kids Health
    • Personal Health
  • Medications
  • Beauty & Balance

Home ยป Spike Protein

Humoral immunity developed by DNA vaccine INO-4800 is effective against SARS-CoV-2 variants

A team of international scientists recently demonstrated that antibodies generated in response to the DNA vaccine INO-4800 can effectively neutralize …

20/04/2021

China's SARS and SARS-CoV-2 outbreak management in comparative perspective

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic – caused by the severe acute respiratory syndrome coronavirus 2 …

17/02/2021

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein …

15/02/2021

New SARS-CoV-2 variant found in newborn child with seizures in the United States

Researchers at a hospital in Washington D.C. found a new mutant strain of the virus in a neonatal patient with …

12/02/2021

Molecular surveillance of SARS-CoV-2 spike protein mutations using CovRadar

COVID-19 disease is caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 was declared a pandemic …

08/02/2021
Categories
  • Beauty & Balance
  • Family Health
  • Health News
  • Health Problems
  • Kids Health
  • Medications
  • Personal Health
Recent Posts
  • Dad devastated after struggling to swallow was sign of silent killer
  • New way to prompt blood vessel growth shows promise for rescuing limbs at risk
  • Timing is everything: How circadian rhythms influence our brains
  • ‘I’m a doctor – here are five body parts you’re not washing enough’
  • Doctor shares sign on your neck that could be a tell-tale sign of diabetes
Copyright © 2025
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok